Extended Follow-up of Type 1 Diabetes Immunotherapy Trial Participants Suggests Benign Side Effect Profile.

Jacobsen LM, Cuthbertson D, Felton J, Sherr JL, Simmons KM, Hosford J, Ismail HM, Greenbaum CJ, Wherrett DK, Pinckney A, Sanda S, DiMeglio LA, Higdon LE, Evans-Molina C

Open source

DOI: 10.2337/dc26-0632
Published: 2026 Aug 1
Container: Diabetes care
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.2337/dc26-0632,
  title = {Extended Follow-up of Type 1 Diabetes Immunotherapy Trial Participants Suggests Benign Side Effect Profile.},
  author = {Jacobsen LM and Cuthbertson D and Felton J and Sherr JL and Simmons KM and Hosford J and Ismail HM and Greenbaum CJ and Wherrett DK and Pinckney A and Sanda S and DiMeglio LA and Higdon LE and Evans-Molina C},
  year = {2026},
  journal = {Diabetes care},
  doi = {10.2337/dc26-0632},
  url = {https://doi.org/10.2337/dc26-0632}
}

RIS

TY  - JOUR
TI  - Extended Follow-up of Type 1 Diabetes Immunotherapy Trial Participants Suggests Benign Side Effect Profile.
AU  - Jacobsen LM
AU  - Cuthbertson D
AU  - Felton J
AU  - Sherr JL
AU  - Simmons KM
AU  - Hosford J
AU  - Ismail HM
AU  - Greenbaum CJ
AU  - Wherrett DK
AU  - Pinckney A
AU  - Sanda S
AU  - DiMeglio LA
AU  - Higdon LE
AU  - Evans-Molina C
PY  - 2026
JO  - Diabetes care
DO  - 10.2337/dc26-0632
UR  - https://doi.org/10.2337/dc26-0632
ER  -

APA

LM, J., D, C., J, F., JL, S., KM, S., J, H., HM, I., CJ, G., DK, W., A, P., S, S., LA, D., LE, H., & C, E. (2026). Extended Follow-up of Type 1 Diabetes Immunotherapy Trial Participants Suggests Benign Side Effect Profile.. Diabetes care. https://doi.org/10.2337/dc26-0632

Source records

pubmed · retrieved 2026-09-26T22:50:30.472Z